Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.78%71.571.0%$655.39m
AMGNAmgen Inc.
-1.27%153.800.8%$502.42m
CELGCelgene Corporation
-1.39%113.621.0%$465.54m
ARIAARIAD Pharmaceuticals, Inc.
0.02%23.7016.4%$429.03m
BIIBBiogen Inc.
-1.15%280.351.0%$389.15m
REGNRegeneron Pharmaceuticals, Inc.
0.13%363.412.5%$362.46m
ALXNAlexion Pharmaceuticals, Inc.
-1.12%134.352.5%$359.12m
ILMNIllumina, Inc.
-0.40%160.583.8%$225.19m
CLVSClovis Oncology, Inc.
0.87%57.1117.9%$163.62m
INCYIncyte Corporation
2.12%117.532.2%$153.09m
VRTXVertex Pharmaceuticals Incorporated
-1.95%80.912.1%$150.84m
TSROTESARO, Inc.
0.44%149.9115.0%$106.95m
SRPTSarepta Therapeutics, Inc.
-4.86%34.2316.8%$106.34m
IONSIonis Pharmaceuticals, Inc.
-0.93%46.708.9%$103.74m
BMRNBioMarin Pharmaceutical Inc.
-1.16%86.154.9%$100.55m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.